Cancer News
IVF conception not linked to increased childhood cancer risk
Children conceived using In Vitro Fertilisation (IVF) and similar techniques have no increased overall risk of cancer in childhood, according to a Cancer Research UK study published in The New England Journal of Medicine.
Less-invasive option as effective as esophagus removal in early esophageal cancer
Use of a minimally invasive endoscopic procedure to remove superficial, early stage esophageal cancer is as effective as surgery that takes out and rebuilds the esophagus, according to a study by researchers at Mayo Clinic in Florida.
Exercise May Help Breast Cancer Survivors Battle Bone Loss
Aerobics and strength-training exercises may help reduce bone loss and the risk of fractures in breast cancer survivors, a new study suggests.
Parents can check their kids for retinoblastoma using digital photography
Can parents use digital cameras and smart phones to potentially screen their children for the most common form of pediatric eye cancer? Baylor University and Harvard Medical School researchers believe so.
Venous Thromboembolisms (VTEs) rise in cancer patients on chemotherapy
The risk of venous thromboembolism (VTE) almost doubled over an 8.5-month period among cancer patients receiving chemotherapy, a retrospective cohort study showed.
Common genetic pathway could be conduit to pediatric tumor treatment
Investigators at Johns Hopkins have found a known genetic pathway to be active in many difficult-to-treat pediatric brain tumors called low-grade gliomas, potentially offering a new target for the treatment of these cancers.
“One-stop” radiotherapy could offer an alternative to lengthy and inconvenient post-surgery procedures for breast cancer
Two new studies, published in The Lancet and The Lancet Oncology, show that targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures – which require women to attend daily radiotherapy sessions for weeks after surgery – for some women undergoing surgery for early breast cancer.
Concurrent therapy not necessary for breast cancer patients with HER-2, study says
Giving trastuzumab and anthracyclines at the same time is effective at treating HER-2-positive breast cancer, but there is concern that this combination can be associated with an increased risk of cardiac toxicity.
New solution in detecting breast-cancer related lymphedema
Viewed as one of the most feared outcomes of breast cancer treatment, doctors struggle detecting and diagnosing breast-cancer related Lymphedema -- a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.
Study finds new explanation for resistance to breast cancer treatment
Breast cancers that initially respond to hormone therapies such as tamoxifen eventually become resistant to treatment, and a new study finds this may be because of a mutation in the receptor present in the cancer cell to which tamoxifen binds, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
Working towards a personalised cancer treatment
Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.
Imbruvica wins FDA OK for rare blood cancer
The FDA approved ibrutinib (Imbruvica) on Wednesday for treatment of patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer.
Low estrogen 'improves efficacy' of PARP inhibitors on womb cancer
Researchers have discovered that low hormone levels may make endometrial cancer tumors more sensitive to a class of medication called PARP inhibitors - drugs that induce cancer cell death. This is according to a study published in the journal Molecular Cancer Therapeutics.
Potential new use for old drugs
A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.
Racial flip seen in pancreatic cancer mortality
Pancreatic cancer mortality has diverged in race-defined directions, increasing in whites and decreasing in blacks for reasons that remain unclear, investigators reported.
No help for hot flashes in prostate cancer
A regimen found useful for treating hot flashes in female cancer patients failed to relieve vasomotor symptoms in prostate cancer patients treated with androgen deprivation therapy (ADT), according to a randomized trial.
Cancer, arthritis treatments could target same 'glue' molecule
Two very different diseases, rheumatoid arthritis and some cancers, share a common feature - an over-abundance of a "glue" molecule that helps cells stick together. Now, a new study suggests targeting this molecule could help treat both.
Scientists fingerprint single cancer cells to map cancer’s family tree
A new method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer’s genetic diversity, new research reveals.
Childhood cancer treatment takes toll on hearts of survivors
Cancer treatment takes a toll on the hearts of child survivors, according to research presented at the American Heart Association's Scientific Sessions 2013.
Reducing copper intake via food and water can slow down tumor growth
Scientists at EPFL have found that copper in drinking water - given at the maximum levels permitted in public water supplies - accelerated the growth of tumors in mice. On the other hand, reducing copper levels reduced tumor growth. The study strongly suggests that copper is an essential factor for the growth of tumors in humans as well.
Obesity a major risk factor in developing "basal-like" breast cancer
Women who are obese face an increased risk of developing an aggressive sub-type of breast cancer known as 'basal-like', according to research conducted at the University of North Carolina.
Adult survivors of childhood cancer at risk of early aging
Young adults who survived childhood cancer are more likely than their peers to be frail, according to a St. Jude Children's Research Hospital study, which reported the condition is more common among female survivors than women decades older. The research appears in the current edition of the Journal of Clinical Oncology.
Scientists finally discover which prostate cancers are life-threatening
Cancer Research UK scientists have discovered that the presence of a specific protein can distinguish between prostate cancers that are aggressive and need further treatment from those that may never seriously harm the patient.
Gene plays major role in suppressing cancer
Adelaide researchers have found that a specific gene plays an important role in suppressing lymphoma, a type of blood cell cancer.
European Commission grants marketing authorization for radium-223 chloride
Bayer HealthCare announced that the European Commission has granted marketing authorization for radium Ra 223 dichloride solution for injection for the treatment of adults with castration-resistant prostate cancer (CRPC), symptomatic bone metastases and no known visceral metastases.
ESMO spearheads international collaboration to assure patient access to safe and effective cancer medicines
The European Society for Medical Oncology (ESMO) has stamped its authority on the international stage by boosting its collaboration with international health and regulatory bodies.
Chronic diseases hinder good cancer survival rates
For bowel cancer patients with several other diseases, the one-year survival rate is 46 percent. For those without other diseases it is 80 percent. The same disparity characterizes other major types of cancer, shows new research based on figures from the Central Denmark Region.
Oral drug may improve survival in men With metastatic prostate cancer
An investigational prostate cancer treatment slows the disease’s progression and may increase survival, especially among men whose cancer has spread to the bones, according an analysis led by the Duke Cancer Institute.
Fish oil may hold promise for prostate cancer
Prostate cancer patients who consumed a low-fat, high fish oil diet had significantly less tissue inflammation and proliferation than patients who ate a typical Western diet, investigators reported.
Roche says Kadcyla wins European approval
Roche said its drug Kadcyla, a treatment for an aggressive form of breast cancer, had been approved in Europe following U.S. approval in February.